Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study

  title={Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study},
  author={Nina Roth and Luc Biedermann and Nicolas Fournier and Matthias Butter and Stephan R. Vavricka and Alexander A. Navarini and Gerhard Rogler and Michael Scharl},
  journal={PLoS ONE},
Background/Aims Extraintestinal cutaneous manifestations of IBD represent a severe disease complication and an early and accurate treatment might positively influence the disease course. Using the patient collective of the Swiss IBD Cohort Study (SIBDCS), we analysed epidemiological as well as clinical factors being associated with the onset of pyoderma gangrenosum, erythema nodosum and aphthous ulcers in IBD patients. Methods We included 3266 SIBDCs patients, 1840 with Crohn’s disease (CD) and… 

Figures and Tables from this paper

The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
Younger age, smoking, low body mass index, anemia, and lower gastrointestinal symptoms were associated with an increased risk of diagnosis of IBD within 3 years in patients with EN, and patients with psoriasis had a 34% increased risk.
Clinical management of the most common extra-intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes
This review aims to create a comprehensive overview of reactive and associated EIMs of inflammatory bowel disease, with the main focus on the treatment of spondyloarthropathies, pyoderma gangrenosum, erythema nodosUM, psoriasis and anterior uveitis.
Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview
The epidemiological, clinical, diagnostic, and histologic features of the most commonly described cutaneous EIMs of IBD along with their respective treatment options are reviewed.
The Temporal Relationships and Associations between Cutaneous Manifestations and Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study
The associations and temporal relationships between cutaneous manifestations and IBD are clarified, highlighting the need for interdisciplinary care in the patient with specific dermatologic diseases presenting with abdominal symptoms, or the IBD patients with cutaneous lesions.
Mucocutaneous manifestations in patients with inflammatory bowel disease: a decade study from a Greek cohort
The presence of MCM was significantly correlated with younger age of IBD diagnosis, longer IBD duration, CD diagnosis, inflammatory behavior and ileal or ileocolonic location of CD, extensive colitis in ulcerative colitis, intestinal manifestations (EIMs) and treatment with immunosuppressant or anti-TNFa.
Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry
Female patients with severe Crohn’s disease represent the group with the highest risk of developing EIMs, and these patients should therefore be specially monitored and referred to the corresponding specialist when suggestive symptoms appear.
Pyoderma Gangrenosum in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
This meta-analysis confirms an association between PG and female gender, Crohn’s disease, erythema nodosum, and ocular EIM that have been described in smaller studies.
North-Western register of patients with inflammatory bowel diseases: achievements and lessons learned
The data of patients’ register is presented, worked out in Mechnikov North-Western State Medical University, in the Centre of IBD treatment, to get a complete picture of patients with IBD in the country and to optimize treatment costs; ensure rational planning and use of budgetary funds.
Dermatological changes associated with non-specific inflammatory bowel diseases – Crohn’s disease and ulcerative colitis
Skin lesions are observed in more than half of patients with inflammatory bowel diseases, and their appearance sometimes precedes development of typical abdominal symptoms, so the awareness of skin manifestations occurring in the course ofinflammatory bowel diseases may contribute to early diagnosis and implementation of therapy.
Clinical Manifestations of Leukocytoclastic Vasculitis, Treatment, and Outcome in Patients with Ulcerative Colitis: A Systematic Review of the Literature
It is found that LCV more commonly occurs after the UC diagnosis, and 68% of patients have active intestinal disease at the time of LCV diagnosis, while Antineutrophil cytoplasmic antibody (ANCA) is positive in 41% of customers, and 36% of Patients have other EIMs present concomitantly with LCV.


Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease.
PG is a rare extra-intestinal manifestation of IBD that coincides with the exacerbation of the intestinal disease but does not always respond to treatment of the bowel disease.
[Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis].
Prevalence of EM in Spanish IBD patients is among the highest ever reported and the distribution of the EM observed is different between CD and UC.
Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes.
EN, uveitis, and arthritis associated with IBD occur together commonly and are associated with genes in the HLA region, and linkage disequilibrium between these genes may account for the clinical picture of overlapping but independent clinical manifestations.
Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort
EIMs are a frequent problem in CD and UC patients and identification of EIM prevalence and associated risk factors may result in increased awareness for this problem and thereby facilitating their diagnosis and therapeutic management.
Skin Manifestations of Inflammatory Bowel Disease
Current knowledge on cutaneous EIMs, their diagnostic criteria and clinical presentation, natural history, pathogenesis, and treatment options are summarized.
Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel Disease
Genetic susceptibility, aberrant self-recognition and immunopathogenic autoantibodies against organ-specific cellular antigens shared by the colon and extra-colonic organs may contribute to the pathogenesis and development of these EIMs.
Significance of Erythema Nodosum and Pyoderma Gangrenosum in Inflammatory Bowel Diseases: A Cohort Study of 2402 Patients
Neither erythema nodosum nor pyoderma gangrenosum was significantly associated with the severity criteria in IBD; however, their occurrence may reflect a peculiar phenotype among affected patients.
Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients.
Bowel-related systemic manifestations appeared frequently together in the same patient and patients with any of these manifestations ran a higher risk of developing another one, and autoimmune manifestations were associated with both Crohn's disease and ulcerative colitis.
Extraintestinal manifestations of inflammatory bowel disease.
  • F. Jose, M. Heyman
  • Medicine
    Journal of pediatric gastroenterology and nutrition
  • 2008
The prevalence (where known) and clinical aspects of the more commonly described EIMs of Crohn disease (CD) and ulcerative colitis (UC) are focused on.
The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study
The associations of immune mediated diseases in extraintestinal sites may help to further the understanding of IBD pathogenesis, and it may help in developing a paradigm of disease subsets.